Genmab A/S (GNMSF) Net income 2023–2025
Genmab A/S (GNMSF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$963.0MFY2025 · since FY2023: $631.0M → $963.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $963.0M | -15.0% |
| FY2024 | $1.1B | +79.6% |
| FY2023 | $631.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net marginGNMSF Gross profitGNMSF Gross marginGNMSF Operating incomeGNMSF Operating marginGNMSF Operating cash flowGNMSF Free cash flowGNMSF Capital expendituresGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →